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Point  by  point  response  
We  appreciate  all   reviewers  and  board  members   for   the   careful   review  of  our  manuscript.  Now,  
with   their  accurate   suggestions,  we  believe   that   our  manuscript   and   figures  have  been   improved  
dramatically.  Concerns  raised  by  the  reviewers  were  addressed  as  following,  and  we  were  glad  to  
correct  these  points  in  the  revised  manuscript.  
  
Reviewer  #1:  Takahara  et  al.  
  
This   manuscript   describes   the   long-­term   culture   of   colitogenic   effector  memory   T   cells.     Unlike  
other  homeostatic   or  diseased   states,   so-­called  T  memory   stem  cells  were  not   found   in  mice  with  
chronic   colitis.     Instead,   long-­lived   effector   memory   CD4   T   cells   were   identified.     These   cells  
survived  in  vitro  in  the  presence  of  IL-­7  but  did  not  proliferate  extensively.     The  results  are  clear  
and  interesting  and  the  experiments  performed  are  believable  and  well  done.  
  
Points:  
1.           There  are  a  few  abbreviations  that  aren't  defined  although  I  could  guess  what  they  were  (SP,  
BM).     Also,  a  few  spelling  errors  (SCID  is  spelled  SICD  on  p12).  
→We  corrected  these  points  in  the  revised  manuscript.  
2.           Figure  3  is  busy  and  confusing.     It   is  mainly  descriptive  and  the  text  does  not  describe  what  
the  results  mean  at  all?     Focusing  on   the   important  or  differently  expressed  markers  would  help  
with  clarity.  
→As  you   suggested,  we   focused  only   important  markers  on  cultured-­LP  CD4+  T  cells   in   revised  
figure  3.  
3.           Why  are   the  results   from  4wk  cultured  cells   so  different   in  Fig  5A  and  Fig  7B?     in  5A,   the  
cells  induce  on-­going  pathology  at  week  3  while  in  7B  it  does  not  appear  until  week  5.     If  the  mice  
from  fig  5A  were  used  in  7B,  there  would  be  no  difference.     Is  7B  an  anomaly  or  is  5A  the  outlier?  
→The  adoptive  transfer  experiment  in  Figure  5  is  different  from  those  in  Figure  7.  We  performed  
each   experiments   separately.   Although   we   uniformed   the   condition   of   donor   cells   and   recipient  
mice  as  much  as  possible,  there  is  some  difference  in  strength  of  colitis  among  each  experiment  in  
this  model.     
  
Reviewer   #2:   The   manuscript   entitled   "IL-­7   promotes   long-­term   in   vitro   survival   of   unique  
long-­lived  memory  subset  generated  from  mucosal  effector  memory  CD4+  T  cells  in  chronic  colitis  
Response to Reviewers
mice"  by  Watanabe  and  colleagues  characterized  an  in  vitro  cultured  long-­lived  "memory"  CD4+  
T  cell  population  that  could   induce  colits   in  vivo.  While   the  manuscript   is  clearly  written,  several  
concerns  are  associated  with  this  model.       
  
Major  comments:  
  
It   is   clear   that   the   cultured   LP  CD4+  T   cells   are   pathogenic,   and   phenotypically   different   from  
primary  LP  CD4+  T  cells.  However,  to  exclude  any  potential  artifact  of  in  vitro  culture  system,  and  
to  conclude  that  "the   in  vitro  cultured  CD4+  T  cell  subset  will  be  a  novel,  effective  target  for  the  
treatment  of  IBD",  the  authors  need  to  justify  that  this  "unique"  cell  population  does  exist  in  vivo.     
→To   exclude   the   potential   artifact   of   in   vitro   system,  we   checked  whether   there   is   a   population  
similar  to  cultured-­LP  CD4+  T  cells  in  vivo  or  not.  As  shown  in  revised  figure  8,  in  the  colitic  mice,  
LP   CD4+CXCR3+CD25+   cells   expressed   higher   level   of   Bcl-­2,   integrin-­a4b7   and   IL-­2   than   the  
other  subsets,  which  means  that  this  subset  is  similar  to  cultured-­LP  CD4+  T  cells.  
  
The   authors   need   to   discuss  why   cultured-­LP  CD4+  T   cells   express   higher   levels   of   gut   homing  
molecules  but  end  up  accumulating  in  the  spleen.  
→In  the  experiment   in  Figure  6,  we  analyzed  colitic  mice  6  weeks  after  the  transfer.  Primary-­LP  
CD4+  T  cell  are  gut  tropic,  so  most  of  them  migrate  to  MLN  of  LP,  while  cultured-­LP  CD4+  T  cells  
might  acquire  the  ability  to  recirculate  to  SP.  In  the  early  time  point,  larger  number  of  cultured-­LP  
CD4+   T   cells   might   accumulate   to   LP   than   primary-­LP   CD4+   T   cells.   However,   after   the  
development  of   colitis,   in   the   effector   site,  LP,  primary  LP  CD4+  T  cells   have  already  expanded  
dramatically,  while  cultured-­LP  CD4+  T  cells  are  quiescent  and  they  have  not  expanded  as  same  as  
primary  LP  CD4+  T  cells.  We  added  this  point  in  discussion  part  of  revised  manuscript.  
  
Minor  comments:  
  
For  cell   surface  marker   staining   (figure  3),   the  authors  need   to   show   isotype/negative  control   for  
gating.  
→We  added  negative  controls  in  revised  figure  3.  
The  authors  need  to  provide  for  each  experiment  how  many  repeats  were  done.  
→We  added  this  information  in  revised  manuscript.  
Highlights 
 
1, Hierarchy of memory T cells previously reported cannot apply to inflammatory 
bowel diseases (IBD) model mice, and that TEM in colitic mice are not short-lived cells 
but include long-lived cells. 
2, We developed for the first time long-term culture system to purify long-lived and 
highly pathogenic memory subset from colitogenic memory CD4+ T cells. 
3, LP CD4+ T cells expressed higher levels of Bcl-2, integrin-Įȕ&;&5DQG&'
after than before culture, as well as secreting high concentrations of IL-2 and low 
concentrations of IFN-ȖDQG,/-17 in response to intestinal bacterial antigens. 
4, LP CD4+ T cells from colitic mice cultured for 8 weeks induced more severe colitis 
than LP CD4+ T cells cultured for 4 weeks.  
5, This subset will be a novel, effective target for the treatment of IBD. This long-term 
culture system will be a useful tool to investigate the maintenance system of long-lived 
memory CD4+ T cells in chronic inflammatory diseases. 
  
*Highlights
Takahara et al 
  
1 
1  
IL-7 promotes long-term in vitro survival of unique long-lived memory 
subset generated from mucosal effector memory CD4+ T cells in 
chronic colitis mice 
Masahiro Takahara*,§, Yasuhiro Nemoto*, Shigeru Oshima*,  
Yu Matsuzawa*, Takanori KanaiÁ, Ryuichi Okamoto*, Kiichiro Tsuchiya*,  
Tetsuya Nakamura*, Kazuhide Yamamoto§, Mamoru Watanabe* 
*Department of Gastroenterology and Hepatology, Graduate School, Tokyo Medical 
and Dental University, Tokyo 113-8519, ÁDivision of Gastroenterology and Hepatology, 
Department of Internal Medicine, Keio University School of Medicine, Tokyo 160-
8582, §Department of Gastroenterology and Hepatology, Okayama University Graduate 
School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama City, Okayama 
700-8558, Japan. 
Corresponding author: Mamoru Watanabe, M.D., Ph.D., Department of 
Gastroenterology and Hepatology, Tokyo Medical and Dental University, 1-5-45 
Yushima, Bunkyo-ku, Tokyo 113-8519, Japan. Tel: +81-3-5803-5973; Fax: +81-3-
5803-0268; E-mail: mamoru.gast@tmd.ac.jp. 
Nonstandard abbreviations used: IBD: inflammatory bowel disease; LP: lamina 
propria; MLNs: mesenteric lymph nodes; SP: spleen; BM: bone marrow; TEM: effector 
memory T (cells); TCM: central memory T (cells); Treg: regulatory T (cells) 
Keywords: inflammatory bowel disease, memory T cells, CD4, IL-7, cell culture
*Manuscript
Click here to view linked References
Takahara et al 
  
2 
2  
Abstract 
Colitogenic memory CD4+ T cells are important in the pathogenesis of inflammatory 
bowel disease (IBD). Although memory stem cells with high survival and self-renewal 
capacity were recently identified in both mice and humans, it is unclear whether a 
similar subset is present in chronic colitis mice. We sought to identify and purify a long-
lived subset of colitogenic memory CD4+ T cells, which may be targets for treatment of 
IBD. A long-lived subset of colitogenic memory CD4+ T cells was purified using a 
long-term culture system. The characteristics of these cells were assessed. Interleukin 
(IL)-7 promoted the in vitro survival for >8 weeks of lamina propria (LP) CD4+ T cells 
from colitic SCID mice previously injected with CD4+CD45RBhigh T cells. These cells 
were in a quiescent state and divided a maximum of 5 times in 4 weeks. LP CD4+ T 
cells expressed higher levels of Bcl-2, integrin-Įȕ CXCR3 and CD25 after than 
before culture, as well as secreting high concentrations of IL-2 and low concentrations 
of IFN-ȖDQG IL-17 in response to intestinal bacterial antigens. LP CD4+ T cells from 
colitic mice cultured with IL-7 for 8 weeks induced more severe colitis than LP CD4+ T 
cells cultured for 4 weeks. We developed a novel culture system to purify a long-lived, 
highly pathogenic memory subset from activated LP CD4+ T cells. IL-7 promoted long-
term in vitro survival of this subset in a quiescent state. This subset will be a novel, 
effective target for the treatment of IBD. 
 
 
 
 
 
 
Takahara et al 
  
3 
3  
1, Introduction 
Inflammatory bowel disease (IBD) is a chronic inflammation of the gastrointestinal tract, 
occurring primarily in younger individuals and usually persisting over long periods of 
time (1). Monoclonal antibodies against TNF-Į have been shown effective in patients 
with ERWK&URKQ¶VGLVHDVH&'DQGXOFHUDWLYHFROLWLV8&, changing the natural history 
of these disorders (2). However, even if these treatments induce remission, these 
patients require life-long maintenance therapy because of the risk of IBD recurrence.  
Pathogenic immunological memory is the primary cause of IBD persistence. Memory T 
cells can survive in a quiescent state, even in patients in life-long remission, with anti-
effector therapy unable to remove these cells. For example, when bacteria translocate 
from the intestinal lumen to the blood circulation as a result of acute infectious colitis, 
memory T cells immediately differentiate to effector cells and exert effector function, 
leading to recurrence. 
We have shown the importance of memory CD4+ T cells in the pathogenesis of chronic 
colitis (3). Using a mouse model of colitis, in which SCID mice were injected with 
CD4+CD45RBhigh T cells, we found that large numbers of CD4+CD44+CD62L- memory 
T cells had infiltrated the colonic lamina propria (LP). These cells expressed high levels 
of the memory cell markers interleukin (IL)-7RĮ and Bcl-2, reproducing colitis upon 
transfer to new SCID mice for up to five transfers. These LP CD4+ cells of colitic mice 
have therefore been described DV³FROLWRJHQLFPHPRU\7FHOOV´ (3).  
Colitogenic memory T cells may be attractive targets for radical treatment of IBD 
without the need for maintenance therapy. Although bone marrow transplantation after 
strong chemotherapy to ablate the UHFLSLHQW¶VKHPDWRSRLHWLFFHOOVwas found to induce 
remission in CD patients without the need for maintenance therapy (4), these treatments 
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can cause severe infection, even death, because these treatments strongly suppress not 
only pathogenic memory T cells, but also protective T cells.  
Memory T cells are heterogeneous and can be divided into two subpopulations. Central 
memory T cells (TCM) reside mainly in the secondary lymphoid organs and are able to 
proliferate, whereas effector memory T cells (TEM) reside mainly in effector sites such 
as intestinal LP and have immediate effector functions (5). Recently, memory stem cells 
(TSCM), with high potential for survival, self-renewal and multi-differentiation, were 
identified in both mice and humans (6). These cells are defined primarily by their 
surface markers, including CD44, a memory and effector marker, and CD62L and 
CCR7, both of which are homing receptors to lymph nodes. The pathway of T cell 
differentiation is thought to consist of Tnaive→TSCM→TCM→TEM→Teffector. TSCM are the 
least differentiated memory cells, have the best proliferative potential and are long-lived, 
whereas TEM are the most differentiated memory cells, have the poorest proliferative 
potential, and are short-lived (7, 8). However, it remains unclear whether this pathway 
is active in IBDs and autoimmune diseases. 
Identifying a key subset of colitogenic memory T cells, i.e. memory stem cells, may 
help develop more effective and safer treatments for IBD. We therefore sought to 
clarify the roles of each subset of memory CD4+ T cells, and to identify the most 
effective fraction to target during radical treatment of IBD.  
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2, Materials and Methods 
2-1, Animals. C57BL/6, Balb/c, CB17-icr SCID mice were purchased from Japan 
CLEA (Tokyo, Japan). RAG-2 deficient mice (RAG-2±/±) were obtained from Taconic 
Laboratory (Hudson, NY) and Central Laboratories for Experimental Animals 
(Kawasaki, Japan). Mice were intercrossed and maintained under specific pathogen-free 
conditions in the Animal Care Facility of Tokyo Medical and Dental University 
(TMDU). Donors and recipients were used at 6±12 weeks of age. All experiments were 
approved by the regional animal study committees and were performed according to 
institutional guidelines and Home Office regulations. 
 
2-2, Antibodies. The following mAbs were obtained from BD PharMingen (San Diego, 
CA) and used for purification of cell populations and flow cytometric analysis: FITC-, 
PE-, PerCP-, and APC-conjugated anti-mouse CD4 (RM4-5); FITC-, PerCP-conjugated 
anti-mouse CD3 (145-2C11); PE-conjugated anti-mouse CD44 (IM7); FITC-conjugated 
anti-mouse CD62L (MEL-14); PE-conjugated anti-mouse IL-17A (TC11-18H10); 
FITC-conjugated anti-mouse IFN-JXMG1.2; FITC-, PE-conjugated anti-mouse Bcl-2 
(3F11); PE-conjugated anti- -Įȕ (DATK32); FITC-conjugated anti-
mouse VβTCR Screening Panel; FITC-conjugated anti-mouse CD69 (H1.2F3); FITC-
conjugated anti-mouse CD45RB (16A); PE-conjugated anti-mouse CD25 (PC61);FITC-
conjugated anti-mouse CD103 (M292); PE-conjugated anti-mouse CD117 (2B8); FITC-
,PE-conjugated streptavidin . The following mAbs were obtained from eBioscience 
(San Diego, CA): biotin-conjugated anti-mouse IL-5Į$5; PerCP-Cy5.5-
conjugated anti-mouse CCR7 (4B12); APC-conjugated anti-mouse Sca-1(D7). The 
following mAbs were obtained from Biolegend (San Diego, CA): PE/Cy7-conjugated 
anti-mouse CD3 (145-2C11);  PE-, Brilliant Violet 421TM-conjugated anti-mouse 
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CXCR3(173); Biotin-conjugated anti- -Įȕ (DATK32); FITC- 
conjugated anti-mouse IL-2(JES6-5H4); PE/Cy7-conjugated anti-mouse IL-17A (TC11-
18H10). The following mAbs was obtained from R&D Systems (Minneapolis, MN): 
PE-conjugated anti-mouse CCR9 (242503). 
 
2-3, Induction of CD4+CD45RBhigh T cells-transfer colitis. CD4+ T cells were 
isolated from the spleens of C57BL/6 and Balb/c mice using the anti-CD4 (L3T4)-
0$&6 V\VWHP 0LOWHQ\L %LRWHF $XEXUQ &$ DFFRUGLQJ WR WKH PDQXIDFWXUHU¶V
instructions. Enriched CD4+ T cells were labeled with PE-conjugated anti-mouse CD4 
(RM4-5; BD Pharmingen, San Diego, CA) and FITC-conjugated anti-CD45RB (16A; 
BD Pharmingen). CD4+CD45RBhigh T cells were isolated using FACS Aria II (Becton 
Dickinson); these cells were 98.0-100% pure on reanalysis. Recipient mice, RAG-2-/- 
mice for C57BL/6J donor cells and CB17-icr SCID mice for Balb/c donors, were 
intraperitoneally injected with 3 x 105 CD4+CD45RBhigh T cells. All mice were 
monitored for clinical signs, including hunched posture, piloerection, diarrhea, and 
blood in the stool. At autopsy, their clinical scores were assessed as the sum of three 
parameters: hunching and wasting, 0 or 1; colon thickening, 0±3 (0, none; 1, mild; 2, 
moderate; or 3, extensive); and stool consistency, 0±3 (0, normal beaded stool; 1, soft 
stool; 2, diarrhea; 3, bloody stool) (3). In some experiments, on going colitis score (0±4 
points) was defined as the sum of hunching and wasting (0 or 1) and stool consistency 
(0, normal beaded stool; 1, soft stool; 2, diarrhea) scores. 
 
2-4, Histological examination. Tissue samples were fixed in PBS containing 6% 
neutral-buffered formalin. Paraffin-embedded sections (5 ȝm) were stained with H&E. 
Three tissue samples from the proximal, middle, and distal parts of the colon were 
prepared. The sections were analyzed without prior knowledge of the type of T cell 
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reconstitution or treatment. The mean degree of inflammation in the colon was 
calculated using a modification of a previously described scoring system (3), consisting 
of the sum of three parameters: crypt elongation, 0-3; mononuclear cell infiltration, 0-3; 
and frequency of crypt abscesses, 0-3. 
 
2-5, Isolation of mononuclear cells from murine organs. Single cell suspensions 
were prepared from the SP, MLN, LP, and BM as described (3). To isolate LP CD4+ T 
cells, the entire length of colon was opened longitudinally, washed with PBS, and cut 
into small pieces. The dissected mucosae were incubated for 45 min with Ca2+-, Mg2+-
IUHH+DQNV¶EDODQFHG VDOW VROXWLRQ FRQWDLQLQJP0'77 6LJPD-Aldrich) to remove 
mucus and then treated with 3.0 mg/ml collagenase (Roche Diagnostics GmbH, 
Germany) and 0.01% DNase (Worthington Biomedical Co., Freehold, NJ) for 2 h. The 
cells were pelleted twice through a 40% isotonic Percoll solution and then subjected to 
Ficoll±Hypaque density gradient centrifugation (40%/75%). Enriched LP CD4+ T cells 
were obtained by positive selection using anti-CD4 (L3T4) MACS magnetic beads. Of 
the resultant cells, >95% were CD4+ cells, as determined by flow cytometry. BM cells 
were obtained by flushing two femurs with cold RPMI-1640. 
 
2-6, Flow cytometry. To detect the surface expression of a variety of molecules, 
isolated SP, BM, MLN and LP mononuclear cells were incubated with specific FITC-, 
PE-, PerCP-, APC- and/or biotin-labeled antibodies for 20 min at 4°C. Standard two-, 
three-, or four-color flow cytometric analyses were performed using FACS Calibur flow 
cytometer and CellQuest software or using FACS Canto-II and Diva software.  
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2-7, Cytokine ELISA. Cytokine production was measured by culturing 1 u 105 LP 
CD4+ T cells at 37°C in a humidified atmosphere containing 5%CO2 in 200 ȝl culture 
medium containing 2 mg/ml hamster anti-mouse CD28 mAb (37.51, BD Pharmingen) 
in 96-well plates (Costar, Cambridge, MA) that had been pre-coated with 5 mg/ml 
hamster anti-mouse CD3e mAb (145-2C11, BD Pharmingen) for 3 hours at 37°C. 
Supernatants were collected 48 hour later, and cytokine concentrations in the 
VXSHUQDWDQWV ZHUH PHDVXUHG E\ (/,6$ DFFRUGLQJ WR WKH PDQXIDFWXUHU¶V
recommendation (R&D Systems). 
 
2-8, Intracellular staining of cytokines. Isolated CD4+ T cells were cultured for 12 
hours with ionomycine (500 ng/ml), PMA (50ng/ml) and BD GolgiPlug (1ȝl/ml BD 
Pharmingen) and collected and their surface molecules were stained. Following cell 
fixation using a Cytofix/Cytoperm Kit (BD Pharmingen), the cells were incubated with 
PE-conjugated anti-IL-17A mAb (TC11-18H10: BD Pharmingen), PE/Cy7-conjugated 
anti-mouse IL-17A (TC11-18H10: Biolegend) and FITC-conjugated anti-IFN-J mAb 
(XMG1.2: BD Pharmingen), FITC- conjugated anti-mouse IL-2(JES6-5H4: Biolegend) 
for 20 min. 
 
 
2-9, Transfer of TCM and TEM from colitic mice to SCID recipients. SP and MLN 
CD4+ T cells from colitic SCID mice previously injected with CD4+CD45RBhigh T cells 
were isolated using the anti-CD4 (L3T4)-MACS system described above. The cells 
were labeled with PerCP-conjugated anti-mouse CD3, APC-conjugated anti-mouse 
CD4, PE-conjugated anti-mouse CD44 and FITC-conjugated anti-CD62L. 
CD3+CD4+CD44+CD62L-TEM and CD3+CD4+CD44+CD62L+ TCM cells from the SP 
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and MLN were sorted using FACS Aria II, and 1 x 104 of each were injected 
intraperitoneally into new SCID mice (n=4). Mice were monitored for up to 16 weeks, 
sacrificed and analyzed. 
 
2-10, Long-term culture of LP CD4+ T cells from colitic SCID mice with anti-CD3e 
antibody, IL-2, IL-15 or IL-7. LP CD4+ T cells were isolated from colitic SCID mice 
previously injected with CD4+CD45RBhigh T cells using the anti-CD4 (L3T4)-MACS 
system and labeled with 2.5 ȝM CFSE ,QYLWURJHQDFFRUGLQJWRWKHPDQXIDFWXUHU¶V
instructions. These cells (3 x 105/well) were cultured in 6 well plates in RPMI 1640 
PHGLXP6LJPDFRQWDLQLQJ)%6+(3(6ȝ0-ME and 
penicillin/streptomycin/L-glutamine, as well as anti-CD3e antibody (5 μg/mL,  BD 
Pharmingen), human recombinant IL-2(10 U/mL, 100 U/mL, or 1000 U/mL;  Shionogi), 
mouse recombinant IL-15 (1 ng/mL, 10 ng/mL, or 100 ng/mL;  PeproTech) or human 
recombinant IL-7 (1 ng/mL, 10 ng/mL, or 100 ng/mL; PeproTech). Fresh medium was 
added once a week. Four weeks later, the CD4+ T cells were collected and analyzed by 
flow cytometory. 
 
2-11, Long-term culture of SP, BM and LP CD4+ T cells from colitic SCID and 
normal Balb/c mice with IL-7. SP, BM and LP CD4+ T cells isolated from colitic 
SCID mice previously injected with CD4+CD45RBhigh T cells and from normal mice 
using the anti-CD4 (L3T4)-MACS system were labeled with 2.5 ȝM CFSE and cultured 
at 1.5 x 105 cells/well in medium with or without human recombinant IL-7 (100 ng/mL), 
with fresh medium added once per week. Four weeks later, the CD4+ T cells were 
collected and analyzed by flow cytometry. 
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2-12, Cytokine production by cultured and primary LP CD4+ T cells in response to 
intestinal bacterial antigens. Cecal bacterial antigens (CBA) were prepared from the 
cecums from colitic SCID mice injected with CD4+CD45RBhigh T cells as previously 
reported (9, 10). Each cecum was opened, placed in 1 ml PBS and vortexed. After 
addition of DNase (10 ȝg/ml), 1 ml of this bacterial suspension was added to 1 ml of 
glass beads. The cells were disrupted at 5,000 rpm in a Mini-Bead Beater (BioSpec 
Products, Bartlesville, OK) for 3 min and placed on ice. The glass beads and unlysed 
cells were removed by centrifugation at 8,000 rpm for 5 min. The lysates were filter-
processed in a similar manner.  
To prepare APCs, spleen cells (2 x 107 cells/5 ml in a 15-ml tube) from normal BALB/c 
mice were incubated with appropriate concentrations of lysates overnight at 37°C, 
washed twice, treated with mitomycin-C, and added to T cell cultures. SP CD4+ T cells 
obtained from normal mice (Normal SP), LP CD4+ T cells freshly isolated from colitic 
CD4+CD45RBhigh T cell-transferred SCID mice (Primaly-LP) and colitic LP CD4+ T 
cells cultured with IL-7 for 8 weeks (Cultured-LP) were cultured in the presence of 
APCs pretreated with CBA in complete media. The supernatants were collected 3 days 
later, and concentrations of IFN-J, IL-17 and IL-2 were measured by ELISA. 
 
2-13, Re-transfer of Cultured- and Primary-LP CD4+ T cells into new SCID mice. 
LP CD4+ T cells isolated from colitic SCID mice previously injected with 
CD4+CD45RBhigh T cells were cultured with 100 ng/ml IL-7 for 4 weeks, as above 
(Cultured-LP CD4+). 1 x 105 of these Cultured-LP CD4+ T cells or the same number of 
LP CD4+ T cells freshly isolated from colitic SCID mice previously injected with 
CD4+CD45RBhigh T cells (Primary-LP CD4+) were injected intraperitonially into new 
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SCID mice (n=5 each). The mice were monitored for up to 15 weeks, sacrificed and 
analyzed. 
2-14, Co-transfer of Ly5.2+ cultured LP CD4+ T cells and Ly5.1+ primary LP CD4+ 
T cells into RAG-2-/- mice. LP CD4+ T cells isolated from colitic RAG-2-/- mice 
previously injected with Ly5.2+CD4+CD45RBhigh T cells were cultured with 100 ng/ml 
IL-7 for 8 weeks (Ly5.2+Cultured-LP CD4+). 3 x 105 Ly5.2+Cultured-LP CD4+ T cells 
and the same number of LP CD4+ T cells freshly isolated from colitic RAG-2-/- mice 
previously injected with Ly5.1+CD4+CD45RBhigh T cells (Ly5.1+Primary-LP CD4+) 
were co-injected intraperitoneally into 8 RAG-2íí mice. The mice were monitored for 
up to 9 weeks, sacrificed and analyzed. 
 
2-15, Re-transfer of 4 and 8 week-cultured LP CD4+ T cells into SCID mice. 3 x 105 
LP CD4+ T cells from colitic SCID mice cultured with 100 ng/ml IL-7 for 4 (cLP 4W; 
n=5) or 8 (cLP 8W; n=5) weeks were injected intraperitoneally into new SCID mice. 
The mice were monitored for up to 7 weeks, sacrificed and analyzed. 
 
2-16, Statistical analysis. We examined the normality of the distribution of results in 
each group. If results from either group were not normally distributed, differences 
between two groups were analyzed using the Mann±Whitney U-test. If results from both 
groups were normally distributed, the variance of the population to which each group 
belonged was assessed using the F-test. When the populations were homoscedastic, 
GLIIHUHQFHV EHWZHHQ WZR JURXSV ZHUH DVVHVVHG XVLQJ 6WXGHQW¶V t-tests; otherwise, 
differences were assessed using Welch¶V t-test. Statcel software was utilized for all 
statistical analyses. Results are expressed as mean ± SEM. Differences were considered 
significant when P < 0.05. 
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3, Results 
3-1, Most CD4+ T cells in mouse models of chronic colitis are effector memory cells. 
We first assessed the diversity of memory CD4+ T cells in several mouse IBD models. 
We observed large numbers of TEM cells and small numbers of TCM cells in the SP and 
MLN of SCID mice previously injected with CD4+CD45RBhigh T cells (Supplemental 
Fig.1A). In contrast, large numbers of TCM, TNaive and TSCM cells and small numbers of 
TEM cells were observed in normal Balb/c mice. Surprisingly, there were no TSCM in 
colitic SCID mice, although continuous colitis occurs in this model. Consistent with 
previous reports, only TEM cells were present in the colonic LP of both colitic SCID and 
normal mice.  
We also compared the expression of Bcl-2, an anti-apoptotic molecule and  TSCM 
marker, in TCM and TEM. SP TCM expressed higher level of Bcl-2 than SP TEM. LP TEM 
also expressed a high level of Bcl-2, similar to that of SP TCM (Supplemental Figure 1B). 
 
3-2, TCM and TEM from colitic SCID mice injected with CD4+CD45RBhighT cells 
induce colitis to the same extent. 
There were no TSCM in colitic mice, but TCM expressed higher level of Bcl-2 than TEM, 
suggesting that TCM have higher survival ability and are more important in chronic 
colitis than TEM. We therefore compared the ability of TCM and TEM to induce colitis in 
SCID mice, by transferring TCM and TEM from SP and MLN of colitic into new SCID 
mice and comparing the severity of colitis (Figure 1A). Both TCM and TEM from colitic 
SCID mice could induce colitis, with no difference in severity, including clinical 
symptoms (Figure 1B, C), histological findings (Figure 1D, E), the number of 
CD3+CD4+ T cells infiltrating the colonic LP (Figure 1F) and the production of IFN-J, 
TNF-D and IL-17 by LP CD4+ T cells (Figure 1G). Interestingly, following the 
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development of colitis, both transferred TCM and TEM cells differentiated to TEM cells in 
recipient mice (Figure 1H). Therefore, we concluded that hierarchy of memory T cells 
previously reported cannot apply to IBD model mice, and that TEM in colitic mice are 
not short-lived cells but include long-lived cells. 
 
3-3, IL-7, but not IL-2 or IL-15, promotion of the in vitro survival of LP CD4+ T 
cells from colitic SCID mice in a quiescent state. 
We next attempted to purify long-lived colitic CD4+ T cells by culturing with IL-7, the 
most important factor for the maintenance of memory CD4+ T cells (11, 12). LP CD4+ 
T cells of colitic SCID mice previously injected with CD4+CD45RBhigh T cells were 
isolated and cultured in medium that included anti-CD3e antibody, IL-2, IL-15 or IL-7. 
IL-7 dose-dependently maintained colitic LP CD4+ T cells in culture for 4 weeks 
(Figure 2A). In contrast, these cells were unable to survive in medium containing anti-
CD3e antibody, IL-2 or IL-15. Next, CD4+ T cells in the SP, BM and LP were isolated 
from these colitic SCID mice and from normal Balb/c mice and were cultured with IL-7. 
Interestingly, CD4+ T cells of normal Balb/c mice, which must include a substantial 
number of memory T cells, could not survive, even in the presence of IL-7, whereas 
CD4+ T cells of colitic mice survived for 4 weeks (Figure 2B), indicating that these 
cells were more sensitive to or dependent on IL-7 than normal CD4+ T cells. CFSE 
assays showed that colitic CD4+ T cells divided a maximum of five times in 4 weeks 
(Figure 2C), indicating that these cells were in a quiescent state and divided 
intermittently. Thus, colitic TEM are not solely short-lived, but may include long-lived 
cells. 
 
Takahara et al 
  
14 
14  
3-4, LP CD4+ T cells express higher levels of Bcl-2, integrin-Įȕ7, CXCR3 and 
CD25 after than before culture. 
We next examined the difference between freshly isolated colitic LP CD4+ T cells 
(Primary-LP CD4+) and those cultured with IL-7 for 4 weeks (Cultured-LP CD4+). 
Cultured-LP CD4+ expressed higher levels of Bcl-2 than Primary-LP CD4+, indicating 
that the former contains higher numbers of long-lived cells than the latter (Figure 3). 
The proportion of TCM was higher in Cultured- than in Primary-LP CD4+ cells, with the 
former expressing higher levels of the TSCM marker CXCR3; integrin-Įȕ, a homing 
receptor for intestines. CD25, the α-chain of the IL-2 receptor, was expressed by most 
Cultured- but by fewer Primary-LP CD4+ cells. In contrast, the levels of expression of 
the activation marker CD69 and of IL-5Įwere lower on Cultured- than on Primary-LP 
CD4+ cells. There was no difference in the expression of the stem cell markers c-kit and 
sca-1 (Figure 3). IL-7 dose dependently increased the proportion of dividing Cultured 
LP CD4+ cells and dose-dependently increased the expression by these cells of CD25 
and Bcl-2, but had no effect on the proportion of TCM (Supplemental Figure 2). 
 
3-5, Production of IL-2, IFN-γ and IL-17 by Cultured-LP CD4+ T cells by 
intestinal bacterial antigens. 
We also assessed whether LP CD4+ T cells could produce cytokines in response to 
intestinal bacterial antigens. Cultured- and Primary-LP CD4+ T cells were co-cultured 
for 72 hours with antigen presenting cells previously pulsed with intestinal bacterial 
antigens, and the concentrations of IL-2, IFN-γ and IL-17 in the supernatant were 
analyzed by ELISA. Cultured-LP CD4+ T cells produced high concentrations of IL-2 
and low concentrations of IFN-γ and IL-17, whereas Primary-LP CD4+ T cells 
produced low concentrations of IL-2 and high concentrations of IFN-γ and IL-17. This 
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result suggests that, during culture, LP CD4+ T cells did not lose their effector function 
against intestinal bacterial antigens. Second, their pattern of cytokine production was 
similar to that of TCM, although the pattern of their surface markers was similar to that 
of TEM (Figure 4).  
 
3-6, Induction of chronic Th1/Th17-mediated colitis by Cultured- and Primary-LP 
CD4+ T cells in vivo. 
To assess whether Cultured-LP CD4+ T cells could induce chronic colitis, 1 x 105 of 
Cultured- or Primary-LP CD4+ T cells were transferred into new SCID mice. SCID 
mice injected with Cultured-LP CD4+ T cells (Cultured-LP) showed apparent on-going 
clinical signs of colitis (Figure 5A), but their end-point clinical score was the same as 
that of mice injected with Primary-LP CD4+ T cells (Primary-LP) (Figure 5B). Both 
Cultured-LP and Primary-LP developed colitis in histological findings (Figure 5C). The 
histological score of the Cultured-LP was higher than that of the Primary-LP group 
(Figure 5D). The numbers of LP CD4+ T cells were similar in both groups (Figure 5E), 
and there were no differences between both groups in the concentrations of IFN-γ, IL-
17 and TNF-α produced by LP CD4+ T cells (Figure 5F). Cultured-LP CD4+ T cells 
could induce chronic colitis to the same extent as primary LP CD4+ T cells. The SP, 
MLN and LP CD4+ T cells in each group were mostly CD44+CD62L-IL-5ĮhighCD69+ 
TEM type cells (Supplemental Figure 3A), and the TCR Vβ repertoire of SP CD4+ T 
cells from both groups were similar (Supplemental Figure 3B). 
 
3-7, Distribution of Ly5.1+ Primary-LP CD4+ T cells and Ly5.2+ Cultured-LP 
CD4+ T cells co-transferred into new RAG-2-/- mice. 
Takahara et al 
  
16 
16  
Although the effector function of Cultured-LP CD4+ T cells was less than that of 
Primary-LP CD4+ T cells in vitro, they had similar colitogenic ability when transferred 
into new SCID mice (Figure 6). We hypothesized that, although Cultured-LP CD4+ T 
cells are quiescent, they can differentiate into effector cells in vivo. We therefore co-
transferred Ly5.1+ Primary-LP CD4+ T cells and Ly5.2+ Cultured LP CD4+ T cells into 
new RAG-2-/- mice and assessed the distribution of Ly5.1+/Ly5.2+ cells in each organ 
after the recipients developed colitis (Figure 6A). Fewer Ly5.2+ Cultured- than Ly5.1+ 
Primary-LP CD4+ T cells were observed in the MLN and LP, whereas more Ly5.2+ 
Cultured- than Ly5.1+ Primary-LP CD4+ T cells were present in the SP (Figure 6B). In 
addition, the proportion of IFN-γ+ IL-17-Th1 cells was lower in Ly5.2+ Cultured- than 
in Ly5.1+ Primary-LP CD4+ T cells (Figure 6C). These results suggest that Cultured-LP 
CD4+ T cells are more quiescent than Primary-LP CD4+ T cells and tend to be 
preserved in the SP. 
 
3-8, LP CD4+ T cells cultured for 8 weeks induced more severe colitis than LP 
CD4+ T cells cultured for 4 weeks. 
Since Cultured-LP CD4+ T cells include larger numbers of quiescent, long-lived 
memory cells than Primary-LP CD4+ T cells, we hypothesized that, during culture, 
long-lived cells can be selected from primary T cells. We therefore compared the ability 
of LP CD4+ T cells cultured for 4 and 8 weeks to induce colitis. LP CD4+ T cells 
cultured with IL-7 for 4 (cLP 4W) and 8 (cLP 8W) weeks were transferred into new 
SCID mice. Four weeks after transfer, mice in the cLP 8W group lost weight, whereas 
mice in the cLP 4W group gained weight (Figure 7A). In addition, the clinical score of 
the cLP 8W group increased gradually 4 weeks after transfer (Figure 7B). The clinical 
and histological scores, as well as the numbers of LP CD4+ T cells, were higher in the 
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cLP 8W than in the cLP 4W group (Figure 7C-E), with cells in the former group 
secreting higher concentrations of IFN-γ, IL-17 and TNF-Į(Figure 7F). Most of the 
SP, MLN and LP CD4+ T cells in each group were CD44+CD62L-IL-5ĮhighCD69+ TEM 
cells (Supplement Figure 4A), with no between group differences in TCR Vβ 
repertoire of SP CD4+ T cells (Supplemental Figure 4B).  
3-9, LP CD4+CXCR3+CD25+ T cells in colitic mice showed similar feature to 
Cultured-LP CD4+ 
To exclude the potential artifact of in vitro system, we checked whether there is a 
population similar to cultured-LP CD4+ T cells in vivo or not. As shown in figure 8, in 
the colitic mice, LP CD4+CXCR3+CD25+ cells expressed higher level of Bcl-2, 
integrin-D4E7 and IL-2 than the other subsets, which means that this subset is similar to 
cultured-LP CD4+ T cells (Figure 8). These results suggest that this subset will be novel 
and effective target of IBD. 
 
4, Discussion 
This study was performed to define a population of long-lived, highly proliferative 
memory T cells, similar to memory stem cells. In assessing the presence of TSCM in 
colitic mice, we observed no CD4+CD44-CD62L+ T cells and no difference between 
TCM and TEM in the ability to induce colitis, indicating that the previously described 
hierarchy of memory T cells cannot be applied to this colitis model.  
In colitic mice, most CD4+ T cells were TEM. Moreover, most TCM transferred into new 
SCID mice differentiated to TEM. TEM cells have been regarded as terminally 
differentiated short-lived cells. Most CD4+ T cells in the colonic LP were thought to be 
TEM or effector T cells, both of which are short-lived and undergo apoptosis in the LP 
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without re-circulation. Furthermore, CD4+ T cells in the T cell transfer model are not 
regarded as memory cells, but as memory-phenotype cells (MP), a type of effector cell 
that differentiates during homeostatic expansion (11, 12). 
We recently reported that LP CD4+ T cells in colitic SCID mice could re-circulate to the 
systemic blood circulation (13) and that colitic LP CD4+ T cells could induce colitis 
upon transfer into new SCID mice (3). We therefore hypothesized that colitic LP CD4+ 
T cells include long-lived memory cells. Although distinguishing memory from effector 
T cells based only on their surface markers is difficult, the most important difference 
between these cell types is their maintenance factors. Effector T cells cannot survive 
without cognate antigens, whereas memory T cells can survive in the presence of 
homeostatic cytokines, including IL-7 or IL-15, even without cognate antigens (14, 15). 
We have shown here that colitic LP CD4+ T cells included a long-lived population, 
which could survive for more than 8 weeks in vitro when cultured with IL-7. Although 
these cells responded to intestinal antigens, both in vitro and in vivo, they could survive 
in the absence of these antigens. During culture, they were quiescent, dividing a 
maximum of five times in 4 weeks, very similar to the homeostatic proliferation of 
memory T cells in vivo (16). To our knowledge, this is the first evidence that colitic LP 
CD4+ T cells include long-OLYHG³PHPRU\´7FHOOV 
Although Primary-LP CD4+ T cells did not include any TCM, Cultured-LP CD4+ T cells 
included a small but substantial number of TCM, suggesting that TEM can differentiate 
into TCM and that the differentiation pathway from TCM to TEM is not always one way, 
but may be plastic. Although TCM were shown to differentiate from TEM or effector T 
cells (17, 18), we found that IL-7 may participate in this pathway. 
Cultured-LP CD4+ cells expressed higher levels of Bcl-2 than Primary-LP CD4+ T cells, 
suggesting that the former are more long-lived. On the other hand, WKH\GLGQ¶WH[SUHVV
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TSCM marker Sca-1 and c-kit, suggesting that this subset is different from memory stem 
cells previously reported (Figure 3). 
Surface markers expressed on Cultured-LP CD4+ cells were unique. 
They had features of both memory and effector. They expressed high levels of CD25, 
while they expressed low levels of CD69, both of which are effector marker. The 
expression of memory marker IL-7Rα on Cultured-LP CD4+ was lower than that on 
Primary-LP CD4+ cells. This result is not inconsistent with our finding that Cultured-LP 
CD4+ are long-lived memory cells, inasmuch as the expression of IL-5ĮLVUHGXFHG
after interaction with a high concentration of IL-7. The reason why CD25 on Cultured-
LP CD4+ were dramatically higher than those on Primary-LP CD4+ is not clear. CD25 
is the alpha chain of IL-2 receptor, a molecule with multiple functions for both effector 
and regulatory T cells (19). Furthermore, IL-2/IL-2R signaling was shown to play an 
important role in the expression of IL-5ĮRQPHPRU\&'+ T cells (20, 21, 22). 
Additional investigations are needed to determine the function of CD25 on Cultured-LP 
CD4+ T cells. 
Cultured-LP CD4+ expressed homing receptors for the intestines, such as integrin-Įȕ7 
and CD103, but expressed high levels of CXCR3, which is also expressed on TSCM, 
suggesting that they have a potential to migrate both to intestine like TEM and another 
site (Figure 3). Actually, as shown in figure 6, a larger number of Cultured-LP CD4+ 
were maintained in SP than Primary-LP CD4+. Since Cultured-LP CD4+ also expressed 
higher level of gut homing receptors, in the early time point, larger number of Cultured-
LP CD4+ might accumulate to LP than Primary-LP CD4+. However, after the 
development of colitis, in the effector site, LP, Primary-LP CD4+ have already 
expanded dramatically, while Cultured-LP CD4+ are quiescent and they have not 
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expanded as same as Primary-LP CD4+, which can explain the smaller number of 
Cultured-LP CD4+ in LP. 
In addition, they secreted a large amount of IL-2, a small amount of TNF-ĮDQG,)1-Ȗ
in response to intestinal antigens, which was very similar of TCM cells (Figure 4). 
In summary, Cultured-LP CD4+ T cells were Bcl-2high long-lived cells, which can be 
defined as CD44+CD62L-CD25highCD69lowintegrin-α4β7highCXCR3high. They had 
potential to migrate to both intestine and spleen. Their production of cytokines was 
similar to TCM. Thus, Cultured-LP CD4+ T cells were different from any memory 
subsets previously reported, so we concluded that they were novel and unique subset. 
Upon co-transfer with Primary LP CD4+ T cells, their proliferation activity was lower. 
When each was transferred alone, however, their effector function and induction of 
colitis were similar. These findings suggested that Cultured-LP CD4+ cells include a 
larger number of long-lived memory cells, which were selected during the culture 
period, than Primary-LP CD4+ T cells, and that fewer Cultured-LP CD4+ T cells were 
required to induce colitis. Indeed, we found that LP CD4+ T cells cultured for 8 weeks 
induced more severe colitis than cells cultured for 4 weeks.  
Although several papers showed that primary CD4+ T cells could be cultured in the 
absence of TCR stimulation up to 2 weeks (23, 24), we here for the first time showed 
that IL-7 could promote more survival of memory CD4+ T cells more than 8 weeks. 
Tumor-protective memory CD8+ T cells could be maintained, in vitro without TCR 
stimulation, but in the presence of IL-2 and IL-7, for more than 6 weeks (25). Thus, the 
maintenance systems for CD4+ and CD8+ memory T cells differ. Indeed, we found that 
CD4+ memory T cells divided a maximum of five times in 4 weeks, consistent with 
results showing that memory CD8+ T cells divided about once a week after the 
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disappearance of cognate antigens in vivo (16). These findings emphasize the novelty 
and uniqueness of our CD4+ memory T cell culture system. 
Our finding, that CD4+ T cells isolated from normal Balb/c mice could not be cultured 
by this method, suggests that memory CD4+ T cells from colitic mice previously 
injected with CD4+CD45RBhigh T cells may be more sensitive or dependent on IL-7. 
Importantly, similar subset, CD4+CD25highCXCR3highintegrin-α4β7highBcl-2highIL-
2high cells existed in LP of colitic mice, which suggests that this subset is not an artificial 
one induced by in vitro system, but a physiological subset. 
In summary, we developed a novel culture system to purify a long-lived, highly 
pathogenic memory subset from activated LP CD4+ T cells. IL-7 promoted long-term in 
vitro survival of this subset in a quiescent state. This subset will be a novel, effective 
target for the treatment of IBD. 
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Figure Legends 
Figure 1 
CD4+ TCM and CD4+ TEM from colitic SCID mice previously injected with 
CD4+CD45RBhighT cells induced colitis. (A) Experimental design. SP 
CD3+CD4+CD44+CD62L+ (SP TCM), SP CD3+CD4+CD44+CD62L- (SP TEM), MLN 
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CD3+CD4+CD44+CD62L+ (MLN TCM) and MLN CD3+CD4+CD44+CD62L- (MLN 
TEM) cells were sorted from colitic SCID mice previously injected with 
CD4+CD45RBhigh T cells and injected into new SCID mice (n=4 per group). The mice 
were monitored for up to 16 weeks, sacrificed and analyzed. (B) Gross appearance of 
the colon, SP and MLN 16 weeks after transfer. (C) Clinical scores. (D) Histopathology 
of the distal colon. (E) Histological scores. (F) Numbers of CD4+CD3+ cells infiltrating 
the colonic LP.  (G) Cytokine production by LP CD4+ T cells. (H) Expression of CD44 
and CD62L on CD3+CD4+ T cells in the SP, MLN and LP. The graph on the right 
shows the percentages of TEM and TCM cells in SP, MLN and LP CD3+CD4+ cells. 
Pictures and dot plots of flow cytometry show representative mice in each group. All 
data are reported as the mean ± SEM. N.S., not significant.  *p<0.01. 
 
Figure 2 
IL-7, but not IL-2 or IL-15, promotes the in vitro survival of LP CD4+ T cells from 
colitic SCID mice previously injected with CD4+CD45RBhighT cells. (A) CFSE-
labeled LP CD4+ T cells obtained from colitic SCID mice previously injected with 
CD4+CD45RBhigh T cells were cultured in medium containing anti-CD3e antibody, IL-2, 
IL-15 or IL-7. Four weeks later, LP CD4+ T cells were analyzed by flow cytometry and 
the numbers of CD3+CD4+ T cells and percentages of CFSELow dividing cells were 
calculated. (B) SP, BM and LP CD4+ T cells of colitic andor normal mice were cultured 
in the presence or absence of IL-7.  Four weeks later, LP CD4+ T cells were analyzed by 
flow cytometry and the numbers of CD3+CD4+ T cells and percentages of CFSELow 
dividing cells were calculated. (C) CFSE-intensity on colitic SP, BM and LP CD4+ T 
cells cultured with IL-7 for 4 weeks. Histogram of flow cytometory shows 
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representative samples from each group. All data are shown as the mean ± SEM for 3 
samples per group. N.S., not significant.  *p<0.01. 
 
Figure 3 
Cultured-LP CD4+ T cells express higher levels of Bcl-2, integrin-Įȕ&;&5
and CD25 than Primary-LP CD4+ T cells. Expression of various surface markers on 
Cultured- and Primary-LP CD4+ T cells. Histograms or dot plots of flow cytometry 
show a representative sample from each group. Numerical values are shown as the 
mean for 3 samples per group. 
Figure 4 
Cultured-LP CD4+ T cells secrete high concentrations of IL-2 and low 
concentrations of IFN-γ and TNF-α in response to intestinal bacterial antigens in 
vitro. Cultured- and Primary-LP CD4+ T cells were each co-cultured for 3 days with 
antigen presenting cells previously pulsed with CBA, and the concentrations of IFN-γ, 
IL-17 and IL-2 in the supernatant were analyzed by ELISA. The negative control 
consisted of SP CD4+ T cells from normal Balb/c mice. Data are expressed as the mean 
± SEM of 3 samples per group.  
Figure 5 
Cultured- and Primary-LP CD4+ T cells induce chronic Th1/Th17-mediated colitis 
to the same extent. 1 x 105 of Cultured- or Primary-LP CD4+ T cells were transferred 
into new SCID mice (n=5 per group). The mice were monitored for up to 11 weeks, 
sacrificed and analyzed. (A) Change in on-going colitis scores. (B) End point-clinical 
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scores. (C) Histopathology of the distal colon. Original magnification: ×100. (D) 
Histological scores. (E) Numbers of LP CD4+CD3+ cells. (F) Intracellular staining of 
IFN-ȖDQG ,/-17 in LP CD4+ T cells. Numerical values are shown as the mean for 5 
samples per group. Pictures and dot plots of flow cytometry of representative samples 
from each group. All data are shown as the mean ± SEM for 5 mice per group. Data are 
representative of three independent experiments. N.S., not significant.  *p<0.01. 
 
Figure 6 
Distribution of Ly5.1+Primary- and Ly5.2+Cultured-LP CD4+ T cells in the SP, 
MLN and LP after co-transfer into new RAG-2-/- mice. (A) Experimental design. 
The same numbers of Ly5.1+ Primary- and Ly5.2+ Cultured-LP CD4+ T cells were co-
injected intraperitonially into new RAG-2íí mice (n=8 per group). The mice were 
monitored for up to 9 weeks, sacrificed and analyzed. (B) Ratio of Ly5.1+ to Ly5.2+ 
CD3+CD4+ T cells in the SP, MLN and LP of RAG-2-/- recipients 9 weeks after transfer. 
(C) Intracellular staining of IFN-ȖDQG,/-17 in Ly5.1+ and Ly5.2+LP CD4+ T cells in 
RAG-2-/- recipients. Numerical values are shown as the mean for 8 mice per group. 
Graphs on the right show the percentages of Ly5.1+ and Ly5.2+ LP CD4+ T cells that 
were IFN-J+IL-17- and IFN-J-L-17+. All data are shown as the mean ± SEM for 8 mice 
per group. N.S., not significant.  *p <0.01. 
 
Figure 7 
LP CD4+ T cells cultured for 8 weeks induced more severe colitis than LP CD4+ T 
cells cultured for 4 weeks. LP CD4+ T cells obtained from colitic SCID mice and 
cultured with IL-7 for 4 (cLP 4W) or 8 (cLP 8W) weeks were transferred into new 
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SCID mice (n=5 per group). Seven weeks later, the mice were sacrificed and analyzed. 
(A) Changes in body weight over time, expressed as the percentage of initial body 
weight. (B) Changes in on-going colitis score. (C) Gross appearance of the colon, 
spleen and mesenteric lymph nodes. (D) Clinical scores. (E) Histopathology of the 
distal colon.  Original magnification: ×100. (F) Histological scores. (G) Numbers of SP, 
MLN and LP CD4+CD3+ cells. (H) Cytokine production by LP CD4+ T cells. Pictures 
show a representative mouse from each group. All data are shown as the mean ± SEM 
for 5 mice per group. N.S., not significant.  *p<0.01. 
 
Figure 8 
LP CD4+CXCR3+CD25+ T cells in colitic mice showed similar feature to Cultured-
LP CD4+ 
LP cells from colitic SCID mice previously transferred with CD4+CD45RBhigh T cells 
were obtained and analyzed. All samples are gated as CD3+CD4+. Histograms or dot 
plots of flow cytometry show a representative sample from each group. Numerical 
values are shown as the mean for 3 samples per group.  
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